Maxime Teisseyre

Nice, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.

Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.

Journal: Kidney international reports
Published: October 08, 2025

Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy.

Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy.

Journal: Kidney international reports
Published: September 25, 2025

Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update

Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update

Journal: La Revue de medecine interne
Published: September 03, 2025

The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial.

The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial.

Journal: EClinicalMedicine
Published: July 30, 2025

Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial.

Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial.

Journal: BMJ open
Published: April 03, 2025

Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.

Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.

Journal: Renal failure
Published: March 27, 2025

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.

Journal: Kidney international reports
Published: March 01, 2025

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Journal: Clinical kidney journal
Published: November 16, 2024

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.

Journal: Kidney international reports
Published: October 02, 2024

Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188].

Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188].

Journal: Kidney international reports
Published: July 31, 2024

Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation.

Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation.

Journal: Kidney international reports
Published: July 29, 2024

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.

Journal: Kidney international reports
Published: June 29, 2023
Showing 1-12 of 25

Last Updated: 09/26/2026